Wellington Management Group
BCAB icon

Wellington Management Group’s BioAtla BCAB Stock Holding History

Wellington Management Group’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7,305
Closed -$979K – 1822
2023
Q1 		$979K Buy
+7,305
New +$1.32M ﹤0.01% 1665
2022
Q3 		– Sell
-618
Closed -$88K – 2029
2022
Q2 		$88K Sell
618
-17,759
-97% -$2.83M ﹤0.01% 2032
2022
Q1 		$4.59M Sell
18,377
-46,273
-72% -$19.4M ﹤0.01% 1414
2021
Q4 		$63.5M Buy
64,650
+18,811
+41% +$24.1M 0.01% 758
2021
Q3 		$67.5M Sell
45,839
-1,586
-3% -$3.09M 0.01% 730
2021
Q2 		$100M Buy
47,425
+17,152
+57% +$38.7M 0.02% 625
2021
Q1 		$77M Buy
30,273
+18,338
+154% +$47M 0.01% 688
2020
Q4 		$20.3M Buy
+11,935
New +$19.9M ﹤0.01% 1032

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group's BCAB Position: Q2 2023 in Review

Wellington Management Group sold out of BioAtla (BCAB) in Q2 2023, closing a stake of 7,305 shares — an estimated $979K sold.

Wellington Management Group first reported a position in BCAB in Q4 2020 and held it in 8 quarters. The position peaked at $100M in Q2 2021. 87 funds tracked by Wall St. Rank hold BCAB as of Q2 2023.

  • Wellington Management Group reported no remaining BioAtla position as of Q2 2023 after selling out during the quarter.
  • Wellington Management Group sold 7,305 BioAtla shares in Q2 2023, an estimated $979K.
  • Wellington Management Group first reported a position in BioAtla in Q4 2020 and held it in 8 quarters.
  • Wellington Management Group's BioAtla position peaked at $100M in Q2 2021.
  • 87 funds tracked by Wall St. Rank held BioAtla as of Q2 2023.

Based on Wellington Management Group's 13F filing for Q2 2023, filed 14 Aug 2023.